News
Former US President Joe Biden diagnosed with prostate cancer, a common cancer in men, with various treatment options ...
Teddi Mellencamp gave an update on her health, including her tumors and her body's response to immunotherapy, during the ...
A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...
Swedish cancer patients treated with CAR T-cell therapy show better survival rates and fewer side effects than seen in ...
Researchers from MIT and Dana-Farber Cancer ... Immunotherapy treatments such as checkpoint blockade inhibitors, which are designed to help stimulate the body's own T cells to attack tumor cells ...
However, the new immuno-based treatment would only require a single step — immunotherapy — to treat the cancer by teaching a person’s immune system to recognize and attack cancer cells.
A new study shows promising results for treating certain cancers with immunotherapy and completely avoiding surgery, radiation and chemotherapy.
Adoptive Cell Transfer (ACT) includes a class of immunotherapy approaches to treat cancer. This procedure focuses on a special type of immune cell called T cells. These cells, particularly the subset ...
The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly delineated, even in phase 3 trials. Although immunotherapy has emerged as an ...
USC biomedical engineers have made this concept a reality, crafting what they have named the "EchoBack CAR T-cell," which could soon be a game changer in the field of cancer immunotherapy.
Immunosuppressive myeloid cells (IMCs) are a prominent driver of immunotherapy resistance in colorectal cancer. This study identifies EP4 ... EP4 is shown as a color cartoon, the residues important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results